AnalystsEva Fortea Verdejo
Eva Fortea Verdejo's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 11%
#562 out of 5223 analysts
Average Return
+34%
Win Rate
66%19 out of 29
Risk vs Reward
Poor
Good

Eva Fortea Verdejo's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Arcus Biosciences IncRCUS
+149.19%$8.01$19.96
2025-05-06 -
2026-02-12
Strong Buy
Merus NvMRUS
+127.08%$41.25$93.67
2025-02-06 -
2025-09-29
Strong Buy
Merus NvMRUS
+119.01%$42.77$93.67
2025-05-07 -
2025-09-29
Strong Buy
Arcus Biosciences IncRCUS
+115.09%$9.28$19.96
2025-08-06 -
2026-02-12
Strong Buy
Revolution Medicines IncRVMD
+107.14%$46.24$95.78
2025-09-10 -
2026-03-20
Strong Buy

Eva Fortea Verdejo's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Relay Therapeutics IncRLAY
4Strong Buy$17.00+71.54%Maintains
6 days ago
Genmab AGMAB
1Strong Buy$40.00+59.36%Initiates Coverage On
21 days ago
Revolution Medicines IncRVMD
2Strong Buy$144.00+50.34%Maintains
25 days ago
Kiniksa Pharmaceuticals International PLCKNSA
4Strong Buy$53.00+15.02%Maintains
a month ago
Arcus Biosciences IncRCUS
5Hold$23.00+6.28%Downgrades
a month ago
Exelixis IncEXEL
1Hold$35.00-15.19%Maintains
a month ago
Zymeworks IncZYME
4Strong Buy$33.00+41.51%Upgrades
3 months ago
Bicara Therapeutics IncBCAX
3Hold$11.00-40.25%Maintains
4 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$60.00+100.60%Initiates Coverage On
5 months ago
Merus NvMRUS
5Hold$97.00+7.78%Downgrades
6 months ago
Iteos Therapeutics IncITOS
7Hold$11.00+8.37%Maintains
8 months ago
Xencor IncXNCR
3Strong Buy$27.00+122.59%Maintains
8 months ago
Ideaya Biosciences IncIDYA
1Strong Buy$44.00+34.35%Initiates Coverage On
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.